Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Nov 2021, 17:31.
John E. Kao - 23 Nov 2021 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 23 Nov 2021
- Net transaction value
- -$8,438,032
- SEC form
- 4
- Accepted by SEC
- 24 Nov 2021, 17:31:55 UTC
- Prior SEC filing
- 03 Nov 2021
- Next SEC filing
- 10 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 24 Nov 2021.
Change
- Previous filing in this sequence was filed on 03 Nov 2021.
- Current net transaction value: -$8,438,032.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Sale
- Transaction value
- $8,438,032
- Shares
- -419,646
- Change %
- -11%
- Price
- $20.11
- Shares after
- 3,565,391
- Date
- 23 Nov 2021
- Ownership
- See footnote
- Footnotes
- F1, F2
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 311,030
- Date
- 23 Nov 2021
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents 419,646 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") sold pursuant to a registered offering which closed on November 23, 2021, at a price of $20.1075 (net of underwriting discount).
Footnote F2
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Footnote F3
Represents 311,030 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date.